Insider · CIK 0001381874
Rubin Steven D
Reports to the SEC for 14 companies · JERUSALEM
Transactions
50
Companies
14
Filings
15
CIK
0001381874
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-08-07 | ENTXEntera Bio Ltd.A Award | — |
| 2026-08-07 | ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award | — |
| 2026-08-07 | ENTXEntera Bio Ltd. · Stock Option (right to buy)A Award | — |
| 2026-07-24 | OPKOPKO HEALTH, INC.F Tax Payment | −$65K |
| 2026-06-24 | NAGENiagen Bioscience, Inc. · Stock Option (right to buy)A Award | — |
| 2026-06-08 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-06-04 | RDVTRed Violet, Inc.A Award | — |
| 2026-02-12 | ENTXEntera Bio Ltd.P Purchase | +$7,450 |
| 2026-02-09 | ENTXEntera Bio Ltd.P Purchase | +$12K |
| 2026-01-24 | ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2026-01-24 | ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2026-01-09 | COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award | — |
| 2025-12-19 | RDVTRed Violet, Inc.A Award | — |
| 2025-09-19 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2025-06-24 | NAGENiagen Bioscience, Inc. · Stock Option (right to buy)A Award | — |
| 2025-05-27 | OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award | — |
| 2025-03-19 | RDVTRed Violet, Inc.S Sale | −$389K |
| 2025-01-24 | ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2025-01-24 | ELOXEloxx Pharmaceuticals, Inc.M Exercise/Conversion | — |
| 2024-11-04 | RDVTRed Violet, Inc.A Award | — |
| 2024-10-16 | ELOXEloxx Pharmaceuticals, Inc.A Award | — |
| 2024-10-09 | COCPCocrystal Pharma, Inc.A Award | — |
| 2024-07-24 | OPKOPKO HEALTH, INC.A Award | — |
| 2024-06-20 | NAGENiagen Bioscience, Inc. · Stock Option (right to buy)A Award | — |
| 2024-01-24 | ELOXEloxx Pharmaceuticals, Inc. · Restricted Stock UnitsA Award | — |
| 2024-01-05 | OPKOPKO HEALTH, INC.P Purchase | +$8,669 |
| 2023-11-30 | RDVTRed Violet, Inc.A Award | — |
| 2023-11-10 | OPKOPKO HEALTH, INC.P Purchase | +$13K |
| 2023-07-18 | COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award | — |
| 2023-06-15 | NAGENiagen Bioscience, Inc. · Stock Option (right to buy)A Award | — |
| 2023-05-25 | NAGENiagen Bioscience, Inc.P Purchase | +$10.2K |
| 2023-05-18 | OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award | — |
| 2023-01-30 | ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award | — |
| 2022-10-12 | RDVTRed Violet, Inc.A Award | — |
| 2022-07-25 | COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award | — |
| 2022-06-16 | NAGENiagen Bioscience, Inc. · Stock Option (right to buy)A Award | — |
| 2022-06-15 | ELOXEloxx Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award | — |
| 2021-09-24 | RDVTRed Violet, Inc.A Award | — |
| 2021-07-16 | COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award | — |
| 2021-06-17 | NAGENiagen Bioscience, Inc. · Stock Options (right to buy)A Award | — |
| 2021-05-19 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-02-19 | OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award | — |
| 2020-11-20 | RDVTRed Violet, Inc.A Award | — |
| 2020-08-26 | OPKOPKO HEALTH, INC.P Purchase | +$10K |
| 2020-08-26 | OPKOPKO HEALTH, INC.P Purchase | +$9,968 |
| 2020-08-26 | OPKOPKO HEALTH, INC.P Purchase | +$20K |
| 2020-06-22 | COCPCocrystal Pharma, Inc. · Stock Options (Right to Buy)A Award | — |
| 2020-06-19 | NAGENiagen Bioscience, Inc. · Stock Options (right to buy)A Award | — |
| 2020-06-04 | OPKOPKO HEALTH, INC. · Stock Option (Right to Buy)A Award | — |
| 2020-05-20 | ELOXEloxx Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award | — |
Recent filings
- 4Rubin Steven D0001178913-26-003957SEC(opens sec.gov)
- 4Rubin Steven D0001193125-26-321041SEC(opens sec.gov)
- 4Rubin Steven D0001381874-26-000001SEC(opens sec.gov)
- 4Rubin Steven D0001193125-26-266275SEC(opens sec.gov)
- 4Rubin Steven D0001193125-26-259844SEC(opens sec.gov)
- 4Rubin Steven D0001193125-26-214983SEC(opens sec.gov)
- 4Rubin Steven D0001178913-26-000508SEC(opens sec.gov)
- 4Rubin Steven D0001178913-26-000412SEC(opens sec.gov)
- 4Rubin Steven D0001493152-26-002033SEC(opens sec.gov)
- 4Rubin Steven D0001193125-25-329097SEC(opens sec.gov)
- 4Rubin Steven D0001628280-25-033063SEC(opens sec.gov)
- 4Rubin Steven D0000950170-25-079112SEC(opens sec.gov)
- 4Rubin Steven D0000950170-25-043394SEC(opens sec.gov)
- 4Rubin Steven D0001104659-25-006783SEC(opens sec.gov)
- 4Rubin Steven D0000950170-24-121713SEC(opens sec.gov)
Companies
- ASENSUS SURGICAL, INC.Director
- BioCardia, Inc.Director, Interim CEO and Interim CFOBCDA
- Castle Brands IncDirector
- Cocrystal Pharma, Inc.DirectorCOCP
- DREAMS INCDirector
- Eloxx Pharmaceuticals, Inc.DirectorELOX
- Entera Bio Ltd.DirectorENTX
- Fluent, Inc.DirectorFLNT
- Niagen Bioscience, Inc.DirectorNAGE
- NON INVASIVE MONITORING SYSTEMS INC /FL/DirectorNIMU
- OPKO HEALTH, INC.Director, Executive VP-AdministrationOPK
- PROLOR Biotech, Inc.Director
- Red Violet, Inc.DirectorRDVT
- VBI Vaccines Inc/BCDirector
Address
KIRYAT HADASSAH, MINRAV BUILDING, 5TH FLOOR
JERUSALEM, 9112002